Cancer of the Colon and Rectum - Cancer Stat Facts. SEER. Accessed June 7, 2025. https://seer.cancer.gov/statfacts/html/colorect.html

Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. JAMA Netw Open. 2022;5(10):e2236666. https://doi.org/10.1001/jamanetworkopen.2022.36666.

Article  PubMed  PubMed Central  Google Scholar 

van der Pool AEM, Damhuis RA, IJzermans JNM, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis. 2012;14(1):56–61. https://doi.org/10.1111/j.1463-1318.2010.02539.x.

Article  PubMed  Google Scholar 

Frankel TL, D’Angelica MI. Hepatic resection for colorectal metastases. J Surg Oncol. 2014;109(1):2–7. https://doi.org/10.1002/jso.23371.

Article  PubMed  Google Scholar 

Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol. 2010;28(13):2300–9. https://doi.org/10.1200/JCO.2009.26.9340.

Article  CAS  PubMed  Google Scholar 

Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341(27):2039–48. https://doi.org/10.1056/NEJM199912303412702.

Article  CAS  PubMed  Google Scholar 

Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer. 1993;71(6):1964–71.

Article  CAS  PubMed  Google Scholar 

Lorenz M, Müller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228(6):756–62. https://doi.org/10.1097/00000658-199812000-00006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer. 1994;73(4):1134–42.

Article  CAS  PubMed  Google Scholar 

Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10(7):1112–8. https://doi.org/10.1200/JCO.1992.10.7.1112.

Article  CAS  PubMed  Google Scholar 

Pak LM, Kemeny NE, Capanu M, et al. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. J Surg Oncol. 2018;117(4):634–43. https://doi.org/10.1002/jso.24898.

Article  CAS  PubMed  Google Scholar 

Kemeny N, Eid A, Stockman J, et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol. 2005;91(2):97–101. https://doi.org/10.1002/jso.20286.

Article  CAS  PubMed  Google Scholar 

Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005;23(22):4888–96. https://doi.org/10.1200/JCO.2005.07.100.

Article  CAS  PubMed  Google Scholar 

Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24(9):1395–403. https://doi.org/10.1200/JCO.2005.03.8166.

Article  CAS  PubMed  Google Scholar 

Kemeny NE, Melendez FDH, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465–71. https://doi.org/10.1200/JCO.2008.20.1301.

Article  PubMed  PubMed Central  Google Scholar 

The Netherlands Cancer Institute. Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: A Randomised Controlled Trial. clinicaltrials.gov; 2025. Accessed June 8, 2025. https://clinicaltrials.gov/study/NCT06857773

ECOG-ACRIN Cancer Research Group. A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial. clinicaltrials.gov; 2024. Accessed June 7, 2025. https://clinicaltrials.gov/study/NCT05863195

Lassen K. EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2. clinicaltrials.gov; 2024. Accessed June 8, 2025. https://clinicaltrials.gov/study/NCT04898504

Memorial Sloan Kettering Cancer Center. A Randomized Phase II Study of Systemic Chemotherapy With or Without HAI FUDR/Dexamethasone in Patients With Unresectable Intrahepatic Cholangiocarcinoma. clinicaltrials.gov; 2025. Accessed June 8, 2025. https://clinicaltrials.gov/study/NCT04891289

Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989;7(11):1646–54. https://doi.org/10.1200/JCO.1989.7.11.1646.

Article  CAS  PubMed  Google Scholar 

Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol. 1985;3(1):98–102. https://doi.org/10.1200/JCO.1985.3.1.98.

Article  CAS  PubMed  Google Scholar 

Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206(6):685–93. https://doi.org/10.1097/00000658-198712000-00001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemeny MM, Battifora H, Blayney DW, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg. 1985;202(2):176–81. https://doi.org/10.1097/00000658-198508000-00007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito K, Ito H, Kemeny NE, et al. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: Incidence, clinical features, and risk factors. Ann Surg Oncol. 2012;19(5):1609–17. https://doi.org/10.1245/s10434-011-2102-8.

Article  PubMed  Google Scholar 

Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229–35. https://doi.org/10.1038/sj.bjc.6602102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chappell R. Competing risk analyses: how are they different and why should you care? Clin Cancer Res. 2012;18(8):2127–9. https://doi.org/10.1158/1078-0432.CCR-12-0455.

Article  PubMed  Google Scholar 

Rao D, Ellis CS, Kemeny N, Cercek A. Case-based clinical guidance on dosing and management of the hepatic artery infusion chemotherapy pump. JCO Oncol Pract. 2024;20(2):187–94. https://doi.org/10.1200/OP.23.00374.

Article  PubMed  Google Scholar 

Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 1992;69(2):327–34.

Article  CAS  PubMed  Google Scholar 

Fortner JG, Silva JS, Cox EB, Golbey RB, Gallowitz H, Maclean BJ. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg. 1984;199(3):317–24. https://doi.org/10.1097/00000658-198403000-00011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fortner JG, Mulcare RJ, Solis A, Watson RC, Golbey RB. Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg. 1973;178(2):162–72. https://doi.org/10.1097/00000658-197308000-00009.

Article  CAS  PubMed  PubMed Central  Google Scholar